文献速递炎症性肠病胃肠动力与功能性疾病

白细胞介素28通过激活上皮信号转导及转录激活因子1控制结肠炎小鼠的黏膜愈合,且在炎症性肠病患者黏膜中升高

Activation of Epithelial Signal Transducer and Activator of Transcription 1 by Interleukin 28 Controls Mucosal Healing in Mice With Colitis and Is Increased in Mucosa of Patients With Inflammatory Bowel Disease.
PubMed 文献 · Gastroenterology · 2017-03-23

研究探讨白细胞介素28A(IL28A/干扰素λ2)在肠上皮细胞激活及黏膜愈合中的作用。在结肠炎小鼠模型及三维肠类器官中,IL28通过激活STAT1促进上皮细胞增殖并加速黏膜愈合;炎症性肠病患者结肠黏膜中IL28及IL28R表达升高。作者认为IL28可能被开发为炎症性肠病的治疗药物。

要点

  • 炎症性肠病患者及结肠炎小鼠结肠固有层细胞IL28表达升高,结肠上皮IL28R表达升高。
  • IL28以剂量依赖方式诱导原代人及小鼠肠上皮细胞STAT1磷酸化。
  • Il28ra-/-、Irf3-/-、Irf3-/-Irf7-/-及Stat1IEC-KO小鼠在右旋糖酐硫酸钠给药后结肠炎较对照小鼠更严重,上皮修复减少。

核心结论

  • IL28通过激活STAT1控制结肠炎小鼠肠上皮细胞增殖并加速黏膜愈合。
  • IL28可能被开发为炎症性肠病患者的治疗药物。

研究设计与样本

  • 研究在C57BL/6JCrl对照小鼠、肠上皮细胞特异性Stat1破坏小鼠(Stat1IEC-KO)、干扰素λ受体1基因破坏小鼠(Il28ra-/-)、干扰素调节因子3基因破坏小鼠(Irf3-/-)及Irf3与Irf7双基因破坏小鼠(Irf3-/-Irf7-/-)中诱导结肠炎。
  • 采用高分辨率微型内镜与活体成像评估结肠炎进展,采用三维小肠及结肠类器官结合RNA-Seq与基因本体方法表征IL28对原代肠上皮细胞的作用。
  • 在伤口愈合实验中研究IL28对人肠道癌细胞系Caco-2的作用,并在小鼠结肠伤口中研究其作用。
  • 对炎症性肠病患者(n=62)及无结肠炎症对照患者(n=23)的结肠活检与切除组织行定量聚合酶链反应检测IL28A、IL28RA及其他相关细胞因子表达,并行免疫荧光分析确定IL28来源。
  • 从患者组织分离肠上皮细胞并与IL28孵育,通过免疫印迹与共聚焦成像检测STAT1磷酸化。

主要发现

  • 炎症性肠病患者结肠组织固有层细胞及结肠炎小鼠的IL28表达较对照增加,炎症性肠病患者及结肠炎小鼠结肠上皮IL28R水平升高。
  • 给予IL28可诱导原代人及小鼠肠上皮细胞STAT1磷酸化,且随剂量增加而增加。
  • Il28ra-/-、Irf3-/-、Irf3-/-Irf7-/-及Stat1IEC-KO小鼠在给予右旋糖酐硫酸钠后结肠炎较对照小鼠更严重,上皮修复减少。
  • Il28ra-/-及Stat1IEC-KO小鼠在给予噁唑酮后结肠炎亦较对照小鼠更严重。
  • IL28诱导上皮细胞STAT1磷酸化(激活),导致其在类器官培养中增殖;给予IL28可促进诱导性结肠伤口小鼠的黏膜愈合。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: We investigated the roles of interleukin 28A (also called IL28A or interferon λ2) in intestinal epithelial cell (IEC) activation, studying its effects in mouse models of inflammatory bowel diseases (IBD) and intestinal mucosal healing. METHODS: Colitis was induced in C57BL/6JCrl mice (controls), mice with IEC-specific disruption of Stat1 (Stat1IEC-KO), mice with disruption of the interferon λ receptor 1 gene (Il28ra-/-), and mice with disruption of the interferon regulatory factor 3 gene (Irf3-/-), with or without disruption of Irf7 (Irf7-/-). We used high-resolution mini-endoscopy and in vivo imaging methods to assess colitis progression. We used 3-dimensional small intestine and colon organoids, along with RNA-Seq and gene ontology methods, to characterize the effects of IL28 on primary IECs. We studied the effects of IL28 on the human intestinal cancer cell line Caco-2 in a wound-healing assay, and in mice colon wounds. Colonic biopsies and resected tissue from patients with IBD (n = 62) and patients without colon inflammation (controls, n = 23) were analyzed by quantitative polymerase chain rection to measure expression of IL28A, IL28RA, and other related cytokines; biopsy samples were also analyzed by immunofluorescence to identify sources of IL28 production. IECs were isolated from patient tissues and incubated with IL28; signal transducer and activator of transcription 1 (STAT1) phosphorylation was measured by immunoblots and confocal imaging. RESULTS: Lamina propria cells in colon tissues of patients with IBD, and mice with colitis, had increased expression of IL28 compared with controls; levels of IL28R were increased in the colonic epithelium of patients with IBD and mice with colitis. Administration of IL28 induced phosphorylation of STAT1 in primary human and mouse IECs, increasing with dose. Il28ra-/-, Irf3-/-, Irf3-/-Irf7-/-, as well as Stat1IEC-KO mice, developed more severe colitis after administration of dextran sulfate sodium than control mice, with reduced epithelial restitution. Il28ra-/- and Stat1IEC-KO mice also developed more severe colitis in response to oxazolone than control mice. We found IL28 to induce phosphorylation (activation) of STAT1 in epithelial cells, leading to their proliferation in organoid culture. Administration of IL28 to mice with induced colonic wounds promoted mucosal healing. CONCLUSIONS: IL28 controls proliferation of IECs in mice with colitis and accelerates mucosal healing by activating STAT1. IL28 might be developed as a therapeutic agent for patients with IBD.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Chiriac MT, Buchen B, Wandersee A, et al. Activation of Epithelial Signal Transducer and Activator of Transcription 1 by Interleukin 28 Controls Mucosal Healing in Mice With Colitis and Is Increased in Mucosa of Patients With Inflammatory Bowel Disease. Gastroenterology. 2017. PMID: 28342759. doi:10.1053/j.gastro.2017.03.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。